Dual Antiplatelet Therapy in Coronary Artery Disease
Abstract Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. While prasugrel demonstra...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Adis, Springer Healthcare
2020-08-01
|
| סדרה: | Cardiology and Therapy |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/s40119-020-00197-0 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
